FAQ Series: The Science Behind Cryopreservation
January 11, 2022Primary cells, such as those isolated from the bone marrow or peripheral blood, are important for a wide scope of research and clinical applications – from studying molecular mechanisms driving disease progression, to […]
GMP-Compliant Leukopaks for Allogeneic Cell Therapies
December 13, 2021Adoptive cell therapies (ACTs), which is a treatment based on transferring cells (most often immune cells) into a patient, have revolutionized the standard of care to treat a broad range […]
GMP-Compliant Leukopaks Mitigate Risk in Cell and Gene Therapy Workflows
December 13, 2021Isolated human primary cells are able to retain the morphological and functional characteristics of their tissue of origin, which makes them invaluable tools in life sciences to advance our understanding […]
T Lymphocytes: A Look at their Role and Research Applications
September 15, 2021T cells are the main effector cells of the adaptive immune system and can be distinguished from other white blood cells by the presence of a T-cell receptor (TCR) on […]
Addition of Eurofins Donor and Product Testing
August 31, 2021Alameda, CA – August 31, 2021. AllCells is committed to providing the best-in-class third-party services complementary to our high-quality products. Due to the increasing demand for extended donor testing, we […]
B Cells: More Than Just Antibodies
August 13, 2021B cells are lymphocytes that are part of the adaptive humoral immune system and are best known for their ability to produce antigen-specific antibodies. B cells express B cell receptors […]
FAQ Series: Comparison of CD34+ Cells from Different Tissue Sources
July 16, 2021Welcome to the second installment of our FAQ blog series! Today, we are looking at differences between CD34+ cells isolated from different tissue sources to provide a better understanding of […]
Clinical Applications of Bone Marrow-Derived Mesenchymal Stem Cells
June 17, 2021While next generation cell-based treatments like CAR-T immunotherapies have been the source of much excitement and clinical investment in recent years, cellular therapies have a long, established history in the […]
FAQ Series: What is the difference between Buffy Coat and Leukapheresis?
June 2, 2021Welcome to the first installment of the FAQ series here on the AllCells blog where we will answer some key questions relating to hematological tissue products. Today, we will unpack […]
Good Manufacturing Practices (GMP) Facilitates Good Products
May 7, 2021With the FDA approvals of several cell therapy products (Kymriah® and Yescarta®) and many more cell therapies progressing towards clinical trials, sourcing high-quality cellular materials has become a critical determinant […]
